Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             141 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements
23 S2 p. ii12
 artikel
2 Author index
23 S2 p. ii51-ii53
 artikel
3 BIG and ESMO page
23 S2 p. ii7
 artikel
4 Editorial Board
23 S2 p. i-ii
 artikel
5 EORTC and Europa Donna page
23 S2 p. ii9
 artikel
6 Europa Donna
23 S2 p. ii9
 artikel
7 EUSOMA and SONK page
23 S2 p. ii11
 artikel
8 Foundation “St.Gallen Oncology Conferences” (SONK)
23 S2 p. ii11
 artikel
9 IMPAKT 2012 Officers
23 S2 p. ii13
 artikel
10 61O Assessment of Response to Neoadjuvant Chemotherapy with Diffusion Weighted Imaging at 3T Pinker-Domenig, K.
23 S2 p. ii32
 artikel
11 60O Assessment of Response to Neoadjuvant Chemotherapy with High Resolution MRI at 3T: Correlation with Pathological Response Pinker-Domenig, K.
23 S2 p. ii32
 artikel
12 14O_PR Biology of Breast Cancer Diagnosed in Young Women: Pooled Gene Expression Analysis From 3522 Patients Azim Jr, H.A.
23 S2 p. ii19
 artikel
13 9O_PR Gene Modules and Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. A Pooled Analysis Ignatiadis, M.
23 S2 p. ii17
 artikel
14 12O_PR Independent Blinded Validation of the Genomic Index of Sensitivity to Endocrine Therapy (Set) Karn, T.
23 S2 p. ii18
 artikel
15 8O_PR MUCIN-1 Protein and Mrna Expression in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Sinn, B.V.
23 S2 p. ii17
 artikel
16 11O Prospective Comparison of Risk Assessment Tools in Early Breast Cancer: Correlation Analysis from the Phase III Wsg-Plan B Trial Gluz, O.
23 S2 p. ii18
 artikel
17 10O_PR Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically-Defined Luminal A Breast Cancer Prat, A.
23 S2 p. ii17-ii18
 artikel
18 78O_PR The Role of Ap-1 in Endocrine-Resistant Breast Cancer Malorni, L.
23 S2 p. ii37
 artikel
19 13O_PR Translational Studies Within the Tamrad Randomized Gineco Trial: Evidence for Torc1 Activation Marker as a Predictive Factor for Everolimus Efficacy in Metastatic Breast Cancer (MBC) Bachelot, T.
23 S2 p. ii18
 artikel
20 100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc) Finn, R.S.
23 S2 p. ii43
 artikel
21 35P Adjuvant Chemotherapy in Node-Negative (N0) Breast Cancer: Routine Upa/Pai-1 Determination Tubiana-Mathieu, N.
23 S2 p. ii24
 artikel
22 69P Adjuvant Postmastectomy Hypofractionated Radiotherapy in Egyptian Cancer Patients, a 2 Years Follow-up Shaltout, E.A.
23 S2 p. ii35
 artikel
23 89P A Feedback Regulatory Loop Between Mir-125B and Brms1 Linked to Breast Tumor Progression Allard, D.
23 S2 p. ii40
 artikel
24 32P Ageing Biomarkers in an Elderly Breast Cancer Population: Correlation with Comprehensive Geriatric Assessment (CGA) Brouwers, B.
23 S2 p. ii23-ii24
 artikel
25 67P Analysis of Local-Regional Recurrence in Young Women (≤ 35Y) Receiving Mastectomy for Operable Breast Cancer Tang, L.C.
23 S2 p. ii34
 artikel
26 4P Analysis of the Toxicity and Tolerability in Adjuvant Vinorelbine and Epirubicine Versus Doxorubicin And Cyclophosphamide For Treating Node Negative Breast Cancer; Randomized Phase II Trial [Avien Study] Kim, K.S.
23 S2 p. ii15-ii16
 artikel
27 15P A Novel RNA Test to Guide Primary Systemic Breast Cancer Chemotherapy Trudeau, M.E.
23 S2 p. ii19
 artikel
28 25P A Novel Serum Thymidine Kinase Activity (S-TK) Assay for Quantification of Total Cell Division in Man, with Special Reference to Breast Carcinoma Gronowitz, S.
23 S2 p. ii22
 artikel
29 6P Antioxidant N-Acetylcysteine Inhibits Cancer-Induced Osteolysis in Mouse Models of Breast-To-Bone Metastasis Pfister, W.
23 S2 p. ii16
 artikel
30 105P Antiproliferative Effect of New Lignan from Abies Sibirica on Hormone-Dependent Breast Cancer Cells in Vitro Zhukova, O.S.
23 S2 p. ii44
 artikel
31 5P Anti-Tumor Effects of Phagelysates of E.Coli Gambashidze, K.
23 S2 p. ii16
 artikel
32 123P Are we Starving our Elective Patients for too long? A Clinical Audit Fussey, J.M.
23 S2 p. ii48
 artikel
33 63P Assessment of Sunitinib Therapy Using an Integrated Micro-Ultrasound and Photoacoustic System in Mouse Breast Cancer Sun, J.
23 S2 p. ii33
 artikel
34 17P Assessment of the Intratumoral Heterogeneity in Metastatic Breast Cancer (Mbc) Through the Analysis of the Frequency of Pik3Ca Mutant Alleles De Mattos-Arruda, L.
23 S2 p. ii19-ii20
 artikel
35 131P Association of Hla Class I and Class Ii Alleles with Breast Cancer in Eastern Indian Population Dasgupta, S.
23 S2 p. ii50
 artikel
36 74P Association of Surgery with Improved Survival in Patients with Metastases at Diagnosis of Breast Cancer Liubota, R.
23 S2 p. ii36
 artikel
37 36P Automated Quantitative Her2 Assessment in Circulating Tumor Cells: Discrepancies with Primary Tumor in Neoadjuvant and Metastatic Trials Bidard, F.
23 S2 p. ii25
 artikel
38 22P BCL2 Negative Breast Tumors but not Axillary Lymph Nodes Predict a Better Overall Survival in Patients Treated with Higher Doses of Epirubicin at a Median follow-up of 15.6 Years Bozovic, I.
23 S2 p. ii21
 artikel
39 54P Biopsies of Recurrent Breast Cancer Increase the Use of Targeted Treatment Hilderson, I.
23 S2 p. ii30
 artikel
40 121P Brain Metastasis and Her-2 Status in Metastatic Breast Cancer (Mbc) in Oman Monem, E. Abdul
23 S2 p. ii48
 artikel
41 127P Breast Cancer and Acute Leukemia Ramadan, S.M.
23 S2 p. ii49
 artikel
42 120P Breast Cancer and Diabetes: Retrospective Study Mehenni, N.
23 S2 p. ii48
 artikel
43 130P Breast Cancer (Bc) in Martinique, Clinical and Pathological Characteristics (Preliminary Results) Bera, O.
23 S2 p. ii50
 artikel
44 122P Breast Cancer Metastases to the Gynecological Organs and Peritoneum: A Single Institution Experience Tomasevic, Z.
23 S2 p. ii48
 artikel
45 34P Breast Cancer Profile in Northern Egypt. Initial Results Hussein, O.
23 S2 p. ii24
 artikel
46 52P Breast Cancer Stem Cells: A Novel Therapy for Breast Cancer Gangopadhyay, S.
23 S2 p. ii29-ii30
 artikel
47 91P Cancer-Associated Fibroblasts Induce High Motility Group Box 1 Expression in Breast Cancer Thuwajit, C.
23 S2 p. ii40
 artikel
48 110P Changes of Serum Vitamin D According to the Breast Cancer Treatment Kim, H.J.
23 S2 p. ii46
 artikel
49 41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis Aurilio, G.
23 S2 p. ii26
 artikel
50 107P Cisplatin and Gemcitabine Combination in Triple Negative Breast Cancer: Community Hospital Experience Hilderson, I.
23 S2 p. ii45
 artikel
51 33P C-Kit Expression in Breast Carcinomas: Correlation with other Clinico-Pathological Parameters Ivkovic-Kapicl, T.
23 S2 p. ii24
 artikel
52 53P Claudins Expression in Breast Cancer: High or Low, What to Expect? Ricardo, S.
23 S2 p. ii30
 artikel
53 124P Clinicopathologic Characteristics of Breast Cancer in Younger Women Results of an Analysis of 219 Cases From A Single Institution Abdelrhman, O.M.
23 S2 p. ii49
 artikel
54 125P Community Therapy by Early Breast Cancer Detection and its Prevention by Lifestyle Modification Koner, S.
23 S2 p. ii49
 artikel
55 94P Comparison of A Novel, Label-Free, and Real-Time cell Based System (Xcelligence) With a Conventional Viability Assay (Xtt) to Determine the Anti-Proliferative Effect of At-101 in Human Breast Cancer Cells Karaca, B.
23 S2 p. ii40-ii41
 artikel
56 48P Comparison of an Rna-Based Multigene Test Between Core Biopsies and Corresponding Surgical Breast Cancer Sections Brase, J.C.
23 S2 p. ii28
 artikel
57 95P Comparison of Expression Levels of Twist, Snail and Slug in Primary Tumors and Lymph Node Metastases in Breast Cancer Patients Ahrends, T.
23 S2 p. ii41
 artikel
58 2P Compliance in Adjuvant Breast Cancer Therapy Vetter, M.
23 S2 p. ii15
 artikel
59 29P Correlation of CD10 and Egfr Expression in Phyllodes Tumors of the Breast Kim, K.S.
23 S2 p. ii23
 artikel
60 83P Correlation of C-Myc with Epithelial-Mesenchymal Transition Phenotype Supernat, A.M.
23 S2 p. ii38
 artikel
61 72P Cosmetic Results of High Dose Rate Brachytherapy Boost Versus Electron Beam Boost in the Treatment of Early Breast Cancer Bhatnagar, A.R.
23 S2 p. ii35
 artikel
62 49P Cost-Effectiveness Evaluation of The 21-Gene Breast Cancer Test in France Rouzier, R.
23 S2 p. ii29
 artikel
63 26P Cost-Effectiveness Review of the 21-GENE Breast Cancer Test Pronzato, P.
23 S2 p. ii22
 artikel
64 46P 3D Digital Breast Tomosynthesis: Role in Recall Rate Reduction in Mammography Screening: An Initial Study on Asian Population Shimpi, T.R.
23 S2 p. ii28
 artikel
65 58P Detection of Human Papillomavirus and Epstein-Barr Virus in Breast Cancer Fard, Z. Tahmasebi
23 S2 p. ii31
 artikel
66 126P Determining the Incidence and Risk Factors of Lymphedema in Breast Cancer Patients Makhdoumi, Y.
23 S2 p. ii49
 artikel
67 40P Development of Circulating Tumor Cell-Endocrine Therapy Index (CTC-ETI) in Metastatic Breast Cancer Patients Paoletti, C.
23 S2 p. ii26
 artikel
68 73P Effect of Local Surgical Treatment on Survival in Metastatic Breast Cancer Patients Alhassanin, S.A.
23 S2 p. ii36
 artikel
69 128P Effect of the Combination of Polyunsaturated Fatty Acid O3 and Chemotherapy in Breast Cancer Cell Lines Damasco-Avila, E.
23 S2 p. ii49-ii50
 artikel
70 106P Egfr Inhibitor in Metastatic Triple Negative Breast Cancer Payandeh, M.
23 S2 p. ii44
 artikel
71 28P Enriched Molecular Function Signatures in Triple Negative and Hormone Receptor Positive Breast Cancer Associated with Metastasis Leyland-Jones, B.
23 S2 p. ii22-ii23
 artikel
72 88P Epo-Independent Functional Epo Receptor in Breast Cancer Enhances Estrogen Receptor Activity and Promotes Cell Proliferation Larsson, A.
23 S2 p. ii39
 artikel
73 82P ER&agr; Expression Regulates Sensitivity to Paclitaxel In Neoadjuvant Chemotherapy for Breast Cancer Tokuda, E.
23 S2 p. ii38
 artikel
74 116P Estimation of Breast Cancer Burden in Iran and its Comparison with Eastern Mediterranean Region and the World Khayamzadeh, M.
23 S2 p. ii47
 artikel
75 119P Evolution and Landscape of Clinical Trials for Breast Cancer Patients Dogan, S.
23 S2 p. ii47
 artikel
76 38P Evolution of Estrogen Receptor (ER) and ErbB2 Expression Between Primary Tumor and Circulating Tumor Cells (CTC) of Metastatic Breast Cancer Patients Doisneau-Sixou, S.
23 S2 p. ii25
 artikel
77 66P Excision of Extra Margins in Breast-Conserving Surgery at the Time of Primary Operation – are there any Clinical or Pathological Factors Associated with Correct Decision-Making? Cook, L.J.
23 S2 p. ii34
 artikel
78 23P Expression Of Beta-Iii Tubulin, Foxo 3 Protein and Deoxythymidine Kinase in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Chow, L.W.C.
23 S2 p. ii21
 artikel
79 80P Expression of Hormad1, A Cancer/Testis Antigen, In Triple-Negative Breast Cancers with High Genomic Instability Grigoriadis, A.
23 S2 p. ii37
 artikel
80 118P Fatigue as a Cause of Sexual Problems in Breast Cancer Patients Cidón, E. Uña
23 S2 p. ii47
 artikel
81 47P Free Hand Breast Core Biopsies in a Selected Group are as Good as Image Guided Biopsies Parvaiz, A.
23 S2 p. ii28
 artikel
82 84P Frequency of 5382Insc and 185Delag Mutation of Brca1 Gene: An Experience from Eastern India Chakraborty, A.
23 S2 p. ii38-ii39
 artikel
83 77P Harmonic Scalpel Vs. Electrocautery Dissection in Modified Radical Mastectomy: Randomized Controlled Trial Khan, S.
23 S2 p. ii36
 artikel
84 19P Her2 Extracellular Domain Levels in Patients With Her2-Positive Early Breast Cancer Experiencing Disease Progression: Case-Control Comparison of Samples from the Hera Study Dowsett, M.
23 S2 p. ii20
 artikel
85 37P HER2 Tumor Heterogeneity and Discrepancies in HER2 Status Between Primary Tumor and Corresponding Circulating Tumor Cells in Metastatic Breast Cancer Patients Migliaccio, I.
23 S2 p. ii25
 artikel
86 45P Hr-Mas Nmr Spectroscopic Assessment of Breast Carcinoma Tissues: Is it Equivalent to Histopathological Examination? Raj, A.
23 S2 p. ii28
 artikel
87 90P Identification in Breast Cancer Cells of A Novel Mechanism of Csf-1R Signaling Which Involves its Nuclear Translocation and Binding to the Promoter of Genes Relevant to Cancer Progression Rovida, E.
23 S2 p. ii40
 artikel
88 79P Identification of A Brcaness Signature in Triple Negative Breast Cancer by Comparative Genomic Hybridization Toffoli, S.
23 S2 p. ii37
 artikel
89 117P Initially Metastatic Versus Recurrent Breast Cancer: Is There any Difference? Mansour, O.M.
23 S2 p. ii47
 artikel
90 39P Invasion and Metastasis Genes Expression Profile of CTCs-Enriched Blood Samples from Breast Cancer Patients Markiewicz, A.
23 S2 p. ii25-ii26
 artikel
91 87P Lack of an Association Between A Functional Polymorphism in the Sex Hormone-Binding Globulin (Shbg) Gene and Breast Cancer Risk: A Meta-Analysis of Case-Control Studies Involving 23,479 Subjects Du, Y.
23 S2 p. ii39
 artikel
92 129P Lapatinib in Her2 Positive Metastatic Carcinoma Breast Behera, M.K.
23 S2 p. ii50
 artikel
93 59P Mammary Duct Endoscopy with Saline Lavage for Breast Cancer Prevention and Homeostasis Maintenance in Middle Aged Women Xu, Z.
23 S2 p. ii31
 artikel
94 64P Mammography and Ultrasonography Reports Compared with Tissue Diagnosis: An Evidence-Based Study, Iran, 2010 Akbari, M.
23 S2 p. ii33
 artikel
95 21P Molecular Characterization of Early-Stage Her2-Overexpressing Breast Cancer (Her2+ Bc) Treated with Adjuvant Trastuzumab: Identification of Prognostic Groups Fumagalli, D.
23 S2 p. ii21
 artikel
96 42P Molecular Profiles of Pre- and Postoperative Breast Cancers Reveal Genes that May be Differentially Expressed After Surgery Riis, M.L.
23 S2 p. ii27
 artikel
97 51P Multiple Primary Neoplasia, or a Neoplasia with Satellites? The Role of Molecular Biology in The Diagnostic Process Deme, D.
23 S2 p. ii29
 artikel
98 16P Myoepithelial Control of the Inflammatory Microenvironment Promotes Transition of Dcis to Invasive Disease Ahmed, K.O.
23 S2 p. ii19
 artikel
99 7P Neoadjuvant Traztuzumab in Locally Advanced Breast Cancer in the Moroccan Population Rhizlane, B.
23 S2 p. ii16
 artikel
100 98P Octreotide in Combination with Docetaxel Triggers Apoptosis by Inducing Sstr2 and Sstr5 Levels in Human Breast Cancer Cells, Mcf-7 and Mda-Mb-231 Karaca, B.
23 S2 p. ii41
 artikel
101 103P P53 Gene Therapy of Human Breast Carcinoma Using a Cationic Non - Viral Vector, Luminescent Silica Nanoparticles Rejeeth, C.
23 S2 p. ii44
 artikel
102 104P Phase II Randomized Study of Pre-Operative Pf-04691502 Plus Letrozole Compared with Letrozole (L) In Patients with Estrogen Receptor-Positive, Her2-Negative Early Breast Cancer (Bc) Dowsett, M.
23 S2 p. ii44
 artikel
103 102P Phase 3 Study Of Nktr-102 Versus Treatment of Physician's Choice (Tpc) in Patients (Pts) with Locally Recurrent or Metastatic Breast Cancer (Mbc) Previously Treated with an Anthracycline, a Taxane, and Capecitabine (Atc) Cortes, J.
23 S2 p. ii43-ii44
 artikel
104 56P Predictors of Axillary Lymph Node Metastases in Women with Breast Cancer Rodionova, M.
23 S2 p. ii30-ii31
 artikel
105 30P Prognostic Impact of Basal, Mesenchymal and Stem Cell Markers in Breast Cancer Zaczek, A.
23 S2 p. ii23
 artikel
106 85P Prognostic Impact of Brca1 and Aldh1 Expression in Sporadic Breast Cancer Ksiazkiewicz, M.
23 S2 p. ii39
 artikel
107 55P Prognostic Role of Palpability in Screen Detected Breast Cancer (BC) Brouckaert, O.
23 S2 p. ii30
 artikel
108 44P Prognostic Value of Detection Method by Breast Cancer (BC) by Phenotype Brouckaert, O.
23 S2 p. ii27
 artikel
109 43P Prognostic Value of Detection Mode in Over 1000 Consecutively Treated Grade 2 Breast Cancers (BC) Brouckaert, O.
23 S2 p. ii27
 artikel
110 24P PTPN9 is a Negative Regulator of HER3 Phosphorylation and a Prognostic Biomarker in HER2 Positive Breast Cancer Gijsen, M.
23 S2 p. ii21-ii22
 artikel
111 20P Qrt-Pcr Based Determination of Her2 Status of Invasive Breast Carcinomas Equivocal by Both Immunohistochemistry (Ihc) and Fluorescence in Situ Hybridization (Fish) Testing Tubbs, R.R.
23 S2 p. ii20-ii21
 artikel
112 112P Quality of Life Among Breast Cancer Patients in Yemen Ali, M.M.S.
23 S2 p. ii46
 artikel
113 27P Quantitative Analysis by Real-Time Pcr for ESR1 Gene Copy Number in Serum in Breast Cancer Samples Martinez-Galan, J.
23 S2 p. ii22
 artikel
114 96P Quantitative Proteomics Profiling of Murine Mammary Gland Cells Unravels Impact of Annexin-1 On Dna Damage, Cell Adhesion and Migration Swa, H.L.F.
23 S2 p. ii41
 artikel
115 18P Relevance and Prediction of Breast Cancer Phenotype in Primary Tumor and its Positive Lymph Nodes and Later Disease Recurrence (Metastatic Breast Cancer): Results of the Primet-Trial (WSG / Detect) Wuerstlein, R.
23 S2 p. ii20
 artikel
116 81P Response to Endocrine and Targeted Therapies in A Large Panel of Patient-Derived Luminal Breast Cancer Xenografts Cottu, P.H.
23 S2 p. ii38
 artikel
117 70P Role of Interstitial Brachytherapy in Early Stage Breast Cancer Behera, M.K.
23 S2 p. ii35
 artikel
118 65P Sentinel Node Biopsy in the Early Breast Cancer Hospital Comarcal La Linea Brito, J.A. Diaz
23 S2 p. ii34
 artikel
119 101P Significant Antitumor Activity in A Randomized Phase 2 Study Comparing 2 Schedules of Nktr-102 In Patients (Pts) with Metastatic Breast Cancer (Mbc) Awada, A.
23 S2 p. ii43
 artikel
120 50P Silver-Enhanced in Situ Hybridization as an Alternative to Fluorescence in Situ Hybridization for Assaying Her2 Amplification in Clinical Breast Cancer Han, S.
23 S2 p. ii29
 artikel
121 132P So The Last Shall be First and The First Shall be Last Parvaiz, A.
23 S2 p. ii50
 artikel
122 71P Study of Dose Distribution of Tangential Beam Intensity Moduleted Radiotherapy Compared to Tangential Beam 3D Conformal Radiotherapy of Chest Wall in Post Mastectomy Breast Cancer Patients Kumbhaj, P.
23 S2 p. ii35
 artikel
123 31P S-Vegf (Vascular Endothelial Growth Factor) as Predictive Factor in Response to Anthracycline Based Chemotherapy in Patients with Locally Advanced Breast Cancer Arya, D.
23 S2 p. ii23
 artikel
124 92P Tff1 Trefoil Protein Involves in Resistance to Doxorubicin-Induced Apoptosis in Breast Cancer Cell Thuwajit, P.
23 S2 p. ii40
 artikel
125 86P The Role of Adam17 in Her2 Moderately Expressing Breast Cancer Feldinger, K.
23 S2 p. ii39
 artikel
126 97P The Role of Id Proteins in the Induction of Tumor-Initiating Cells During Pulmonary Colonization of Metastatic Breast Cancer Stankic, M.
23 S2 p. ii41
 artikel
127 1P Trastuzumab in the Adjuvant Setting: Retrospective Study Mehenni, N.
23 S2 p. ii15
 artikel
128 108P Treatment of Metastatic Breast Cancer with Alternative Vinorelbine and Gemcitabine Bensalem, A.
23 S2 p. ii45
 artikel
129 109P Updated Results of the Bolero-2 Phase Iii Trial Evaluating Everolimus (Eve) for Postmenopausal Women with Advanced Breast Cancer (Abc) Rugo, H.
23 S2 p. ii46
 artikel
130 57P Validation of Three Breast Cancer Nomograms for Predicting the Non-Sentinel Lymph Node Metastases and a New Formula for Predicting Non-Sentinel Lymph Node Status. (Second Study from Turkey-First Unicenter Study) Derici, S.Z.
23 S2 p. ii31
 artikel
131 68P When is a Close or Positive Margin Following a Mastectomy an Indication for Chest Wall Radiotherapy in Patients with T1N0 Breast Cancer? Iganej, S.
23 S2 p. ii34-ii35
 artikel
132 3P Which is Your Choice? Neoadjuvant Doxorubicin and Doxetaxel (Ad) Versus Doxorubicin, Cyclophosphamide and Paclitaxel (Act) in Locally Advanced Breast Cancer Kim, K.S.
23 S2 p. ii15
 artikel
133 76P Wide Local Excision of Breast Cancer Under Local Anaesthetic: A Treatment Option Parvaiz, A.
23 S2 p. ii36
 artikel
134 99P Zoledronic Acid in Combination with Serine/Threonine Phosphatase Inhibitors Induces Cytotoxicity and Apoptosis in Human Breast Cancer Cells via Decreasing the Activities of Pp1 and Pp2A Surmeli, Z.G.
23 S2 p. ii42
 artikel
135 62P 89ZR-Bevacizumab Pet Imaging in Primary Breast Cancer Gaykema, S.B.M.
23 S2 p. ii32
 artikel
136 Subject index
23 S2 p. ii54-ii55
 artikel
137 Table of Contents
23 S2 p. iv
 artikel
138 The European Oncology Nursing Society (EONS)
23 S2 p. iii
 artikel
139 The European Society for Medical Oncology (ESMO)
23 S2 p. ii7
 artikel
140 Translational research index
23 S2 p. ii56
 artikel
141 Welcome from Chairs
23 S2 p. ii14
 artikel
                             141 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland